Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (2)
P 1 (1)
P 2 (1)

Trial Status

Not Yet Recruiting2
Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT07566065Not ApplicableNot Yet RecruitingPrimary

Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis

NCT07511309Not ApplicableNot Yet RecruitingPrimary

FFR-Guided Revascularization in Atherosclerotic Renal Artery Stenosis

NCT01840540Phase 1CompletedPrimary

MSC for Occlusive Disease of the Kidney

NCT02044835Phase 2UnknownPrimary

The Evaluation Studies of Curative Effect of Fu-zheng-qu-zhuo Oral Liquid in Treatment of Ischemic Nephropathy

Showing all 4 trials

Research Network

Activity Timeline